bupivacaine has been researched along with andrographolide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, Q; Wang, W; Zhang, H | 1 |
1 other study(ies) available for bupivacaine and andrographolide
Article | Year |
---|---|
Andrographolide attenuates bupivacaine-induced cytotoxicity in SH-SY5Y cells through preserving Akt/mTOR activity.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Bupivacaine; Cell Proliferation; Diterpenes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Oxidative Stress; Proto-Oncogene Proteins c-akt; Structure-Activity Relationship; TOR Serine-Threonine Kinases; Tumor Cells, Cultured | 2019 |